↓ Skip to main content

STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas

Overview of attention for article published in Breast Cancer Research, January 2012
Altmetric Badge

Readers on

mendeley
129 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas
Published in
Breast Cancer Research, January 2012
DOI 10.1186/bcr3100
Pubmed ID
Authors

Szeman Ruby Chan, William Vermi, Jingqin Luo, Laura Lucini, Charles Rickert, Amy M Fowler, Silvia Lonardi, Cora Arthur, Larry JT Young, David E Levy, Michael J Welch, Robert D Cardiff, Robert D Schreiber

Abstract

Although breast cancers expressing estrogen receptor-α (ERα) and progesterone receptors (PR) are the most common form of mammary malignancy in humans, it has been difficult to develop a suitable mouse model showing similar steroid hormone responsiveness. STAT transcription factors play critical roles in mammary gland tumorigenesis, but the precise role of STAT1 remains unclear. Herein, we show that a subset of human breast cancers display reduced STAT1 expression and that mice lacking STAT1 surprisingly develop ERα+/PR+ mammary tumors.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 129 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Poland 1 <1%
Australia 1 <1%
Unknown 126 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 31 24%
Researcher 21 16%
Student > Bachelor 12 9%
Student > Master 11 9%
Student > Doctoral Student 8 6%
Other 15 12%
Unknown 31 24%
Readers by discipline Count As %
Agricultural and Biological Sciences 38 29%
Biochemistry, Genetics and Molecular Biology 28 22%
Medicine and Dentistry 16 12%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Immunology and Microbiology 4 3%
Other 6 5%
Unknown 33 26%